Clinical trial
Genetic Markers of Circulating Tumor DNA for Monitoring Breast Cancer in Patients of the Hospital San Juan de Dios From 2018 to 2020.
NCT04163159 is registered in ClinicalTrials.gov with Universidad de Costa Rica as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Genetic Markers of Circulating Tumor DNA for Monitoring Breast Cancer in Patients of the Hospital San Juan de Dios From 2018 to 2020.
- Lead sponsor
- Universidad de Costa Rica
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 7, 2019
- Completion date
- November 30, 2020
- Enrollment
- 25 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic breast cancer, mutation, point